Form 4 for GILD Gilead Sciences
Accepted 2025-02-19 00:00:00 ET · period of report 2025-02-18 · accession 0001127602-25-005525 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-02-19 | 2025-02-18 | GILD | Dickinson Andrew D | CFO | S - Sale | $104.09 | -2,500 | 169.1K | -1% | -$260.2K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-02-18 | S | D | 2,500 | $104.09 | 169,061 | D | — | — | (F2) Balance adjusted to reflect shares acquired under the Gilead Sciences, Inc. Employee Stock Purchase Plan. |